Newly licensed drugs.
作者信息
Ferner R E
出版信息
BMJ. 1996 Nov 9;313(7066):1157-8. doi: 10.1136/bmj.313.7066.1157.
Abstract
摘要
相似文献
1
Newly licensed drugs.新获批药物。
BMJ. 1996 Nov 9;313(7066):1157-8. doi: 10.1136/bmj.313.7066.1157.
2
Overhauling oversight--European drug legislation.全面改革监管——欧洲药品立法
Nat Biotechnol. 2005 Sep;23(9):1050-3. doi: 10.1038/nbt0905-1050.
3
M.D.s and marijuana. What you need to know about Minnesota's medical cannabis law.医学博士与大麻。你需要了解的明尼苏达州医用大麻法律。
Minn Med. 2014 Nov-Dec;97(11-12):40-2, 45.
4
Statins: is OTC actually OTT?他汀类药物：非处方药真的用药过量了吗？
Int J Clin Pract. 2003 Nov;57(9):750-1.
5
Medicines regulation in the United Kingdom.英国的药品监管
Health Bull (Edinb). 1990 Sep;48(5):219-24.
6
Government responds to Agriculture Committee's report on medicines.政府回应农业委员会关于药品的报告。
Vet Rec. 1996 Jan 27;138(4):74-5.
7
TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION.《与贸易有关的知识产权协定》第31条（b）款：修订的必要性。
Seton Hall Law Rev. 2016;46(3):883-909.
8
Successful procurement. A licence to spend money?
Health Serv J. 1997 Jun 19;107(5558):suppl 1-5.
9
The ongoing regulation of generic drugs.仿制药的持续监管。
N Engl J Med. 2007 Nov 15;357(20):1993-6. doi: 10.1056/NEJMp078193.
10
Patent protection for medical technologies: why some and not others?
Lancet. 1998 Feb 14;351(9101):518-9. doi: 10.1016/S0140-6736(97)02432-X.
引用本文的文献
1
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.SGLT2 抑制剂在糖尿病肾病患者中的心血管、肾脏和安全性结局的相关性：一项荟萃分析。
Cardiovasc Diabetol. 2022 Mar 23;21(1):47. doi: 10.1186/s12933-022-01476-x.
2
Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials.绿茶提取物对人体肝脏相关的安全性评估：随机对照试验的系统评价
Eur J Clin Nutr. 2016 Nov;70(11):1221-1229. doi: 10.1038/ejcn.2016.78. Epub 2016 May 18.
3
Drug safety assessment in clinical trials: methodological challenges and opportunities.临床试验中的药物安全性评估：方法学挑战与机遇。
Trials. 2012 Aug 20;13:138. doi: 10.1186/1745-6215-13-138.
4
Antibiotics and allergic disorders in childhood.儿童期的抗生素与过敏性疾病
Open Nurs J. 2008;2:48-57. doi: 10.2174/1874434600802010048. Epub 2008 May 22.
5
How NICE may be outflanked.英国国家卫生与临床优化研究所（NICE）可能如何被智取。
BMJ. 2006 May 27;332(7552):1268-71. doi: 10.1136/bmj.332.7552.1268.
6
The influence of big pharma.大型制药公司的影响。
BMJ. 2005 Apr 16;330(7496):855-6. doi: 10.1136/bmj.330.7496.855.
7
Failures of the therapeutic chain as a cause of drug ineffectiveness.作为药物无效原因的治疗链失败。
BMJ. 2003 Apr 26;326(7395):895-6. doi: 10.1136/bmj.326.7395.895.
8
Prescribing new drugs: qualitative study of influences on consultants and general practitioners.新药处方：对顾问医生和全科医生影响因素的定性研究
BMJ. 2001 Aug 18;323(7309):378-81. doi: 10.1136/bmj.323.7309.378.
9
The quantity and quality of clinical practice guidelines for the management of depression in primary care in the UK.英国初级保健中抑郁症管理临床实践指南的数量和质量。
Br J Gen Pract. 1999 Mar;49(440):205-10.
10
The need for pharmacoeconomic evaluations in the NHS.英国国家医疗服务体系（NHS）中药物经济学评估的必要性。
Pharmacoeconomics. 1998 Sep;14(3):241-50. doi: 10.2165/00019053-199814030-00001.
本文引用的文献
1
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.拉莫三嗪和氨己烯酸在严重难治性癫痫中的长期应用：疗效审计
BMJ. 1996 Nov 9;313(7066):1184-5. doi: 10.1136/bmj.313.7066.1184.
2
Drug trials in epilepsy.癫痫药物试验
BMJ. 1996 Nov 9;313(7066):1158. doi: 10.1136/bmj.313.7066.1158.
3
Storage and disposal of embryos and gametes.胚胎与配子的储存及处置
BMJ. 1996 Jul 6;313(7048):1-2. doi: 10.1136/bmj.313.7048.1.
4
Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.他汀类药物降低已有或无冠心病患者胆固醇浓度的成本效益：应用于卫生当局人群的生命表法
BMJ. 1996 Jun 8;312(7044):1443-8. doi: 10.1136/bmj.312.7044.1443.
5
Growth in the use of antibiotics in the community in England and Scotland in 1980-93.1980 - 1993年英格兰和苏格兰社区抗生素使用情况的增长
BMJ. 1996 Mar 9;312(7031):613. doi: 10.1136/bmj.312.7031.613.
6
Health care: what's science got to do with it?医疗保健：科学与之有何关系？
BMJ. 1995 Jan 28;310(6974):208. doi: 10.1136/bmj.310.6974.208.
7
Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.药物警戒：失而复得还是推迟到来？1994年威廉·威瑟林讲座
J R Coll Physicians Lond. 1995 Jan-Feb;29(1):41-9.
8
Probability of adverse events that have not yet occurred: a statistical reminder.尚未发生的不良事件的概率：一则统计学提示。
BMJ. 1995 Sep 2;311(7005):619-20. doi: 10.1136/bmj.311.7005.619.
9
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.普伐他汀预防高胆固醇血症男性冠心病。苏格兰西部冠心病预防研究组。
N Engl J Med. 1995 Nov 16;333(20):1301-7. doi: 10.1056/NEJM199511163332001.
Zotero 插件